Drug inducible transgene expression in brain using a herpes simplex virus vector

Gene Therapy

Volumn 5, Issue 4, 1998, Pages 491-496

  Oligino, T ^a   Poliani, P L ^a   Wang, Y ^b   Tsai, S Y ^b   O'Malley, B W ^b   Fink, D J ^a   Glorioso, J C ^a,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Gene therapy; HSV; RU486

Indexed keywords

MIFEPRISTONE; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE TRANSFER; HERPES SIMPLEX VIRUS; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPORTER GENE; TRANSGENE;

ANIMALIA; HERPES; SIMPLEXVIRUS;

EID: 0031893434     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300612     Document Type: Article

References (32)

1. Akli S et al. Transfer of a foreign gene into the brain using adenovirus vectors. Nat Genet 1993; 3: 224-228
2. Kaplitt MG et al. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet 1994; 8: 148-154.
3. Federoff HJ et al. Expression of NGF in vivo, from a defective HSV-1 vector, prevents effects of axotomy on sympathetic neurons. Proc Natl Acad Sci USA 1992; 89: 1636-1640.
4. Fink DJ et al. In vivo expression of beta-galactosidase in hippocampal neurons by HSV-mediated gene transfer. Hum Gene Ther 1992; 3: 11-20
5. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 1992; 89: 5547-5551.
6. Wang Y et al. A novel regulatory system for gene transfer. Proc Natl Acad Sci USA 1994; 91: 8180-8184.
7. Wang Y et al Ligand-inducible and liver-specific target gene expression in transgeneic mice. Nat Biotechnol 1997; 15: 239-243.
8. Heikmheimo O, Haukkamaa M, Lahteenmaki P. Distribution of RU486 and its demethylated metabolites in humans. J Clin Endocrinol Metab 1989; 68: 270-275.
9. Ulmann A, Peyron R, Silvestre L. Clinical uses of mifepristone. Ann NY Acad Sci 1995; 761: 248-260.
10. Oligino T et al. In vivo transgene activation from an HSV-based gene therapy vector by Ga14:VP16. Gene Therapy 1996; 3: 892-899.
11. DeLuca NA, McCarthy AM, Schaffer PA. Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J Virol 1985; 56: 558-570.
12. Hall B, Milcarek C. Sequence and polyadenylation site determination of the murine immunoglobulin gamma 2a membrane 3′ untranslated region. Molec Imnunol 1989; 26: 819-826.
13. Mayo KE, Warren R, Palmiter RD. The mouse metallothionein-I gene is transcriptionally regulated by cadmium following transfection into human or mouse cells. Cell 1982; 29: 99-108.
14. Palmiter RD et al. Metallothionein-human GH fusion genes stimulate growth of mice. Science 1983; 222: 809-814.
15. Lu B, Federoff HJ. Herpes simplex virus type 1 amplicon vectors with glucocorticoid-inducible gene expression. Hum Gene Ther 1995; 6: 419-428.
16. Lee F et al. Glucocorticoids regulate expression of dihydrofolate reductase cDNA in mouse mammary tumour virus chimaeric plasmids. Nature 1981; 294: 228-232.
17. Braselmann S, Graninger P, Busslinger M. A selective transcriptional induction system for mammalian cells based on Ga14-estrogen receptor fusion proteins. Proc Natl Acad Sci USA 1993; 90: 1657-1661.
18. No D, Yao TP, Evans RM. Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc Natl Acad Sci USA 1996; 93: 3346-3351.
19. Baim SB et al. A chimeric mammalian transactivator based on the lac represser that is regulated by temperature and isopropyl beta-D-thiogalactopyranoside. Proc Natl Acad Sci USA 1991; 88: 5072-5076.
20. Alhonen L et al. Transgenic mice expressing the human ornithine decarboxylase gene under the control of mouse metallothionein I promoter. Biochem J 1996; 314: 405-408.
21. Rafferty JA et al. Tissue-specific expression and induction of human O6-alkylguanine-DNA alkyltransferase in transgenic mice. Molec Carcinogen 1992; 6: 26-31.
22. Stout JT et al. Expression of human HPRT in the central nervous system of transgenic mice. Nature 1985, 317: 250-252.
23. Shockett P et al. A modified tetracycline-regulated system provides autoregulatory, inducible gene expression in cultured cells and transgenic mice. Proc Natl Acad Sci USA 1995; 92: 6522-6526.
24. Furth PA et al. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc Natl Acad Sci USA 1994; 91: 9302-9306.
25. Ho DY, McLaughlin JR, Sapolsky RM. Inducible gene expression from defective herpes simplex virus vectors using the tetracycline-responsive promoter system. Brain Res Mol Brain Res 1996; 41: 200-209.
26. Klaassen CD. Heavy metals and heavy metal antagonists. In: Hardman JG, Limbird LE, Molinoff PB et al (eds). Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th edn. McGraw-Hill Health Professions Division: New York, 1996, pp 1649-1671.
27. Kistner A et al. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci USA 1996; 93: 10933-10938.
28. Mester JC, Pitha P, Glorioso JC. Anti-viral activity of herpes simplex virus vectors expressing alpha-interferon. Gene Therapy 1995; 2: 187-196.
29. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press: New York, 1989.
30. Jain V, Magrath I. A chemiluminescent assay for quantitation of beta-galactosidase in the femtogram range: application to quantitation of beta-galactosidase in lacZ-transfected cells Anal Biochem 1991; 199: 119-124.
31. Martin C et al. Dual luminescence-based reporter gene assay for luciferase and β-galactosidase. BioTechniques 1996; 21: 520-524.
32. Paxinos G, Watson C. The Rat Brain in Stereotactic Coordinates. Academic Press: New York, 1982.